Sign in
4/A

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-307194

Chief Development Officer sold 4,500 shares at $80.90 ($364,070)

  • Chief Development Officer gave 5,287 shares (gift)
  • Chief Development Officer acquired 5,287 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-17 Gift : show line 1 in the form −5,287 0 D
2025-11-17 Other acquisition : show line 2 in the form +5,287 5,287 I
2025-11-25 Sale : show line 3 in the form −4,500 $80.90 $364,070 787 I
Open-market sales · 4,500 sh · avg $80.90 · $364,070
Loading xslF345X05/ownership.xml…